MCID: PPL002
MIFTS: 51

Papillary Carcinoma

Categories: Cancer diseases

Aliases & Classifications for Papillary Carcinoma

MalaCards integrated aliases for Papillary Carcinoma:

Name: Papillary Carcinoma 12 14
Carcinoma, Papillary 41 69
Papillary Carcinoma Nos 12
Carcinoma Papillary 51

Classifications:



External Ids:

Disease Ontology 12 DOID:3113
MeSH 41 D002291
NCIt 46 C2927
SNOMED-CT 64 189562005 25910003
UMLS 69 C0007133

Summaries for Papillary Carcinoma

Disease Ontology : 12 A carcinoma that is derives from epithelial cells with finger like projections.

MalaCards based summary : Papillary Carcinoma, also known as carcinoma, papillary, is related to renal cell carcinoma, papillary, 1 and primary peritoneal carcinoma. An important gene associated with Papillary Carcinoma is TG (Thyroglobulin), and among its related pathways/superpathways are Endometrial cancer and Gastric cancer. The drugs BCG vaccine and Alkylating Agents have been mentioned in the context of this disorder. Affiliated tissues include thyroid, breast and lymph node, and related phenotypes are cellular and homeostasis/metabolism

Related Diseases for Papillary Carcinoma

Diseases related to Papillary Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 348)
# Related Disease Score Top Affiliating Genes
1 renal cell carcinoma, papillary, 1 33.8 KRT7 MET PAX8
2 primary peritoneal carcinoma 33.3 ERBB2 PGR RET
3 breast papillary carcinoma 33.2 ERBB2 NCOA4 PGR RET
4 papillary serous adenocarcinoma 31.6 KRT20 KRT7 NKX2-1 PGR
5 thyroiditis 30.8 CALCA RET TG TPO TSHR
6 renal cell carcinoma, nonpapillary 30.0 CDH1 KRT19 KRT20 KRT7 MET MUC1
7 peritoneal mesothelioma 30.0 MET MUC1 PGR
8 intracystic papillary adenoma 30.0 ERBB2 PGR
9 teratoma 30.0 KRT20 KRT7 NKX2-1
10 thyroid carcinoma, familial medullary 29.9 CALCA NKX2-1 RET TG
11 histiocytic sarcoma 29.9 BRAF LGALS3 MUC1
12 papillary adenoma 29.8 KRT7 NKX2-1
13 struma ovarii 29.7 BRAF NKX2-1 RET TG TSHR
14 cystic teratoma 29.7 KRT20 KRT7 NKX2-1
15 subacute thyroiditis 29.6 TG TPO TSHR
16 mucoepidermoid carcinoma 29.6 CALCA ERBB2 KRT7 MUC1 TG
17 thyroid cancer, anaplastic 29.5 BRAF NKX2-1 PAX8 RET TG
18 adenocarcinoma in situ 29.4 KRT20 KRT7 PAX8
19 graves disease 1 29.4 TG TPO TSHR
20 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 29.3 TG TPO TSHR
21 ductal carcinoma in situ 29.3 CDH1 ERBB2 MUC1 PGR
22 hyperthyroidism 29.2 TG TPO TSHR
23 thyroid cancer, nonmedullary, 2 29.2 BRAF CALCA KRT19 LGALS3 NKX2-1 PAX8
24 in situ carcinoma 29.2 CDH1 ERBB2 PGR
25 hypothyroidism 29.1 NKX2-1 PAX8 TG TPO TSHR
26 squamous cell carcinoma 29.1 BRAF CDH1 ERBB2 KRT19 KRT7 MUC1
27 malignant struma ovarii 29.1 KRT19 LGALS3 NCOA4 NKX2-1 RET TG
28 adenocarcinoma 28.9 BRAF CDH1 ERBB2 MET MUC1 RET
29 lymphoepithelioma-like carcinoma 28.8 CDH1 KRT20 KRT7 MUC1
30 goiter 28.8 CALCA NKX2-1 PAX8 TG TPO TSHR
31 multinodular goiter 28.7 CALCA NKX2-1 PAX8 TG TPO TSHR
32 congenital hypothyroidism 28.5 NKX2-1 PAX8 TG TPO TSHR
33 hashimoto thyroiditis 28.4 CALCA KRT19 LGALS3 RET TG TPO
34 ovarian cancer 28.3 BRAF CDH1 ERBB2 KRT7 MET MUC1
35 thyroid cancer, nonmedullary, 1 28.2 BRAF CALCA CDH1 KRT19 LGALS3 MET
36 follicular adenoma 28.2 CALCA KRT19 LGALS3 NKX2-1 PAX8 RET
37 thyroid cancer 25.8 BRAF CALCA CDH1 KRT19 LGALS3 MET
38 tall cell variant papillary carcinoma 12.1
39 gallbladder papillary carcinoma 12.1
40 primary peritoneal serous/papillary carcinoma 12.0
41 ovary papillary carcinoma 12.0
42 thyroid carcinoma, papillary, with papillary renal neoplasia 11.9
43 kidney pelvis papillary carcinoma 11.9
44 familial renal papillary carcinoma 11.9
45 bladder urothelial papillary carcinoma 11.9
46 columnar cell variant papillary carcinoma 11.9
47 papillary carcinoma of the cervix uteri 11.9
48 penis papillary carcinoma 11.8
49 papillary carcinoma of the corpus uteri 11.8
50 papillary thymic adenocarcinoma 11.2

Graphical network of the top 20 diseases related to Papillary Carcinoma:



Diseases related to Papillary Carcinoma

Symptoms & Phenotypes for Papillary Carcinoma

MGI Mouse Phenotypes related to Papillary Carcinoma:

43 (show all 15)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.35 KRT19 CDH1 KRT7 LGALS3 ERBB2 BRAF
2 homeostasis/metabolism MP:0005376 10.3 CDH1 KRT7 ERBB2 BRAF NCOA4 PGR
3 endocrine/exocrine gland MP:0005379 10.27 KRT19 CDH1 ERBB2 BRAF PGR NKX2-1
4 cardiovascular system MP:0005385 10.25 KRT19 CDH1 ERBB2 BRAF MET PGR
5 growth/size/body region MP:0005378 10.22 KRT19 CDH1 ERBB2 BRAF PAX8 MET
6 mortality/aging MP:0010768 10.18 KRT19 CDH1 ERBB2 BRAF PAX8 MET
7 digestive/alimentary MP:0005381 10.13 KRT19 CDH1 ERBB2 BRAF NKX2-1 LGALS3
8 embryo MP:0005380 10.11 KRT19 CDH1 ERBB2 BRAF PAX8 MET
9 neoplasm MP:0002006 10.07 CDH1 ERBB2 LGALS3 BRAF KRT19 PGR
10 nervous system MP:0003631 10.02 BRAF KRT19 ERBB2 PAX8 MET NKX2-1
11 limbs/digits/tail MP:0005371 9.98 ERBB2 PAX8 MET PGR TPO TSHR
12 normal MP:0002873 9.81 KRT19 CDH1 ERBB2 BRAF MET PGR
13 no phenotypic analysis MP:0003012 9.8 KRT19 CDH1 PAX8 MET NKX2-1 RET
14 reproductive system MP:0005389 9.65 KRT19 CDH1 ERBB2 BRAF PGR NKX2-1
15 skeleton MP:0005390 9.28 KRT19 ERBB2 BRAF PAX8 NKX2-1 LGALS3

Drugs & Therapeutics for Papillary Carcinoma

Drugs for Papillary Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 57)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
BCG vaccine Investigational Phase 3
2 Alkylating Agents Phase 3,Phase 2
3 Adjuvants, Immunologic Phase 3
4 Vaccines Phase 3
5 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
6 Antibiotics, Antitubercular Phase 3,Phase 2
7 Mitomycins Phase 3
8 Nucleic Acid Synthesis Inhibitors Phase 3
9
Paclitaxel Approved, Vet_approved Phase 2,Phase 1 33069-62-4 36314
10
Carboplatin Approved Phase 2,Phase 1 41575-94-4 10339178 38904 498142
11
Iodine Approved, Investigational Phase 2,Phase 1 7553-56-2 807
12
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
13
Everolimus Approved Phase 2 159351-69-6 6442177
14
Sirolimus Approved, Investigational Phase 2 53123-88-9 46835353 6436030 5284616
15
Trametinib Approved Phase 2 871700-17-3 11707110
16
Trastuzumab Approved, Investigational Phase 2 180288-69-1 9903
17
Lenalidomide Approved Phase 1, Phase 2 191732-72-6 216326
18
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
19
Pembrolizumab Approved Phase 2 1374853-91-4
20
Lenvatinib Approved, Investigational Phase 2 417716-92-8
21
Maleic acid Experimental Phase 1, Phase 2 110-16-7 444266
22
Cediranib Investigational Phase 1, Phase 2 288383-20-0 9933475
23 Hormones Phase 2
24 Fluorides Phase 2
25 cadexomer iodine Phase 2,Phase 1
26 Fluorodeoxyglucose F18 Phase 2,Phase 1
27 Micronutrients Phase 2
28 Mitogens Phase 2
29 Albumin-Bound Paclitaxel Phase 2,Phase 1
30 Trace Elements Phase 2
31 Deoxyglucose Phase 2
32 Endothelial Growth Factors Phase 2
33 Anti-Infective Agents Phase 2,Phase 1,Not Applicable
34 Antifungal Agents Phase 2
35 Immunoglobulins Phase 2
36 Immunosuppressive Agents Phase 2,Phase 1
37 Anti-Infective Agents, Local Phase 2,Not Applicable
38 Antibodies Phase 2
39 Radiopharmaceuticals Phase 2,Phase 1
40 Bendamustine Hydrochloride Phase 2
41 Protein Kinase Inhibitors Phase 2,Phase 1
42 Angiogenesis Inhibitors Phase 1, Phase 2
43 Angiogenesis Modulating Agents Phase 1, Phase 2
44 Antibodies, Monoclonal Phase 2
45 Antimitotic Agents Phase 2,Phase 1
46 Antineoplastic Agents, Phytogenic Phase 2,Phase 1
47
Cisplatin Approved Phase 1 15663-27-1 2767 441203 84093
48
Iron Approved 7439-89-6 23925
49
Ethanol Approved Not Applicable 64-17-5 702
50
Formaldehyde Approved, Vet_approved 50-00-0 712

Interventional clinical trials:

(show all 42)

# Name Status NCT ID Phase Drugs
1 Surgery and BCG in Treating Patients With Bladder Cancer Completed NCT00002990 Phase 3
2 Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC Completed NCT01137097 Phase 2, Phase 3
3 Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery Completed NCT00002807 Phase 3
4 Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma Completed NCT00795782 Phase 3
5 Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumor Not yet recruiting NCT03335059 Phase 3
6 RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe Completed NCT00688753 Phase 2 RAD001
7 RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe Completed NCT00688623 Phase 2 Everolimus
8 Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer Completed NCT00867503 Phase 2 Bendamustine HCL
9 Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine Completed NCT00559949 Phase 2 Selumetinib
10 Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Completed NCT00729157 Phase 2
11 Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer Completed NCT00770185 Phase 2 ridaforolimus
12 Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy Recruiting NCT02768753 Phase 1, Phase 2
13 Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer Recruiting NCT02393690 Phase 2 Selumetinib
14 Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer Recruiting NCT02152995 Phase 2 Trametinib
15 Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Active, not recruiting NCT01367002 Phase 2 Carboplatin/Paclitaxel;Trastuzumab
16 Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Active, not recruiting NCT00416455 Phase 1, Phase 2 ferumoxtran-10
17 Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer Active, not recruiting NCT01811212 Phase 2 Cabozantinib S-malate
18 Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid Cancer Active, not recruiting NCT01208051 Phase 1, Phase 2 Cediranib Maleate;Lenalidomide
19 Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery Active, not recruiting NCT00381641 Phase 2 Sunitinib Malate
20 Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer Not yet recruiting NCT03081858 Phase 1, Phase 2 TSD-001
21 Pembrolizumab and Lenvatinib in Treating Metastatic or Recurrent Differentiated Thyroid Cancer That Cannot Be Removed by Surgery Not yet recruiting NCT02973997 Phase 2 Lenvatinib
22 Toremifene in Treating Patients With Ovarian Cancer Withdrawn NCT00003865 Phase 2 toremifene
23 Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery Completed NCT00448643 Phase 1 Cisplatin
24 Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors Terminated NCT02313012 Phase 1 CC-90003
25 Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma Unknown status NCT02648399
26 Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid Unknown status NCT00984191
27 Influence of Thyroid Hormones on the Woundhealing Process Unknown status NCT00929318
28 Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis Unknown status NCT01384669
29 Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients Completed NCT01150318 Administration of 131 iodine
30 APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS. Completed NCT02323724
31 Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study Completed NCT01927887 Ferumoxytol
32 Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors Completed NCT00001668
33 Long-term Outcomes of Total Thyroidectomy Versus Less Than Total Thyroidectomy for Papillary Thyroid Microcarcinoma Completed NCT01648569
34 A Gene Hunting Study for Familial Papillary Thyroid Cancer Recruiting NCT02776969
35 Active Surveillance of Papillary Thyroid Microcarcinoma Recruiting NCT02609685 Not Applicable
36 Active Surveillance on Papillary Thyroid Microcarcinoma Recruiting NCT02938702
37 Active Surveillance of Papillary Thyroid Microcarcinoma Recruiting NCT02952612
38 Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma Recruiting NCT01974284 Not Applicable percutaneous ethanol ablation
39 Expression of Protein Convertases in Thyroid Nodules Enrolling by invitation NCT03160482
40 Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine Not yet recruiting NCT02774395
41 A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC Not yet recruiting NCT03327636 Not Applicable
42 Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma Not yet recruiting NCT03432299 Not Applicable

Search NIH Clinical Center for Papillary Carcinoma

Cochrane evidence based reviews: carcinoma, papillary

Genetic Tests for Papillary Carcinoma

Anatomical Context for Papillary Carcinoma

MalaCards organs/tissues related to Papillary Carcinoma:

38
Thyroid, Breast, Lymph Node, Ovary, Lung, Kidney, Endothelial

Publications for Papillary Carcinoma

Articles related to Papillary Carcinoma:

(show top 50) (show all 773)
# Title Authors Year
1
Papillary Carcinoma of Thyroid with Nasal Cavity Metastases: A Case Report. ( 29398758 )
2018
2
Expression and Distribution of Galectin-3 in Chromophobe and Papillary Carcinomas. ( 29277781 )
2018
3
Intracystic papillary carcinoma of the male breast: a case report. ( 29361955 )
2018
4
Rosettes in papillary carcinoma of thyroid: A rare cytomorphological indicator of aggressive variants. ( 29165889 )
2017
5
Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma. ( 28789361 )
2017
6
A potential role for the Hippo pathway protein, YAP, in controlling proliferation, cell cycle progression, and autophagy in BCPAP and KI thyroid papillary carcinoma cells. ( 28804541 )
2017
7
Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma. ( 28682915 )
2017
8
18F-FDG PET/CT of Papillary Carcinoma in a Lateral Thyroglossal Duct Cyst. ( 28525461 )
2017
9
Papillary Carcinoma Arising in a Thyroglossal Duct Cyst. ( 28492409 )
2017
10
Treatment of a giant pulmonary emphysematous cyst with primary bronchoalveolar papillary carcinoma in a Shih Tzu dog. ( 27898174 )
2017
11
Impact of the Reclassification of the Non-Invasive Follicular Variant of Papillary Carcinoma as Benign on the Malignancy Risk of the Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis Study. ( 28445876 )
2017
12
Anaplastic Spindle Cell Squamous Carcinoma Arising from Tall Cell Variant Papillary Carcinoma of the Thyroid Gland: A Case Report and Review of the Literature. ( 28484653 )
2017
13
A confusing lesion of thyroid papillary carcinoma. ( 29446823 )
2017
14
Papillary carcinoma of the thyroid in patients with primary hyperparathyroidism: Is there a link? ( 28571792 )
2017
15
A Case of Thyroid Papillary Carcinoma: Remarkable Decrease in Multiple Lung Metastases within 40 Years after a Single Administration of Radioiodine without Thyroidectomy and with Later Anaplastic Transformation. ( 29279694 )
2017
16
Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation. ( 28731042 )
2017
17
Evaluation of the presence of Epstein-Barr virus (EBV) in Iranian patients with thyroid papillary carcinoma. ( 28554750 )
2017
18
Infiltrating Ductal Carcinoma Co-Existing with Intraductal Papillary Carcinoma of Male Breast: A Rare Case Report. ( 28764176 )
2017
19
The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast. ( 28625953 )
2017
20
Papillary carcinoma in struma ovarii. ( 28251552 )
2017
21
Solid papillary carcinoma of the breast with an associated Cytokeratin 7- negative Paget's disease of the nipple. Report of a first case. ( 29265587 )
2017
22
Hashimoto's thyroiditis - an independent risk factor for papillary carcinoma. ( 28964693 )
2017
23
Cytodiagnosis of papillary carcinoma of the male breast: Report of a case with histological correlation. ( 28469321 )
2017
24
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory BehAset disease uveitis and concomitant bladder papillary carcinoma. ( 28891187 )
2017
25
An Indian Tertiary Care Hospital Scenario of Papillary Carcinoma of Thyroid. ( 28764174 )
2017
26
Expression of nm23-H1 and COX-2 in thyroid papillary carcinoma and microcarcinoma. ( 28521457 )
2017
27
Defining Papillary Carcinoma of the Thyroid: A Short Review and Analysis. ( 28898991 )
2017
28
Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma. ( 28770103 )
2017
29
Associations Between Nucleus Size, and Immunohistochemical Galectin-3, Cytokeratine-19 and Hbme-1 Markers in Thyroid Papillary Carcinoma: A Morphometric Analyze. ( 29150742 )
2017
30
Thyroid cancer: Overdiagnosis of papillary carcinoma - who benefits? ( 28059158 )
2017
31
Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy. ( 29250166 )
2017
32
Warthin-like variant of thyroid papillary carcinoma. ( 28923670 )
2017
33
Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast. ( 27438988 )
2016
34
Hashimoto's thyroiditis and papillary carcinoma in an adolescent girl: A case report. ( 27330783 )
2016
35
Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases. ( 27116593 )
2016
36
An Incidental Primary Papillary Carcinoma Arising in a Thyroglossal Duct Cyst: Report of a Rare Finding. ( 27013817 )
2016
37
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma. ( 27793057 )
2016
38
Dual malignancy in adolescence: A rare case report of metachronous papillary carcinoma of thyroid following dysgerminoma of ovary. ( 27904567 )
2016
39
Sparing Surgery for the Successful Treatment of Thyroid Papillary Carcinoma Invading the Trachea: A Case Report. ( 27990114 )
2016
40
Intracystic Papillary Carcinoma of the Breast in a Male Patient. ( 27134706 )
2016
41
Genetic landscape of a case of extraovarian peritoneal serous papillary carcinoma. ( 27698805 )
2016
42
Papillary carcinoma of hyoid. ( 27750175 )
2016
43
Can New Ultrasound Signs Help in Identifying Follicular Variant of Papillary Carcinoma of Thyroid? - A Pilot Study. ( 27689170 )
2016
44
An Unusual Solitary Thyroid Nodule with Bloody Follicles: Metastatic Renal Cell Carcinoma Within an Infiltrative Follicular Variant Papillary Carcinoma. ( 26951109 )
2016
45
Well differentiated papillary carcinoma of thyroid presenting as metastatic liver mass. ( 26890713 )
2016
46
The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC). ( 26894377 )
2016
47
Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma. ( 27566169 )
2016
48
Risk Factors of Lymphnode Metastasis in Patients with Thyroid <br/>Papillary Carcinoma Associated with Graves Disease. ( 27825413 )
2016
49
Solid papillary carcinoma of the nipple: an in situ carcinoma or an expansive growth tumor? ( 28195265 )
2016
50
Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma. ( 26715280 )
2016

Variations for Papillary Carcinoma

Expression for Papillary Carcinoma

Search GEO for disease gene expression data for Papillary Carcinoma.

Pathways for Papillary Carcinoma

GO Terms for Papillary Carcinoma

Biological processes related to Papillary Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription, DNA-templated GO:0045893 9.8 CDH1 NCOA4 NKX2-1 PAX8 RET
2 MAPK cascade GO:0000165 9.67 BRAF ERBB2 MET RET
3 hormone biosynthetic process GO:0042446 9.32 TG TPO
4 positive regulation of adenylate cyclase activity GO:0045762 9.26 CALCA TSHR
5 entry of bacterium into host cell GO:0035635 9.16 CDH1 MET
6 thyroid-stimulating hormone signaling pathway GO:0038194 8.96 PAX8 TSHR
7 thyroid gland development GO:0030878 8.92 BRAF NKX2-1 PAX8 TG

Molecular functions related to Papillary Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transmembrane receptor protein tyrosine kinase activity GO:0004714 9.13 ERBB2 MET RET
2 thyroid-stimulating hormone receptor activity GO:0004996 8.62 PAX8 TSHR

Sources for Papillary Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....